Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma

Abstract Objective The aim of this study was to investigate the efficacy and safety of the combined treatment regimen of D-TACE, HAIC, and Lenvatinib in patients with massive hepatocellular carcinoma, with the goal of providing a safer and more effective therapeutic strategy for individuals sufferin...

Full description

Bibliographic Details
Main Authors: Haohao Lu, Bin Liang, Chuansheng Zheng, Xiangwen Xia
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-13179-5